Your session is about to expire
← Back to Search
Cryoablation
Cryoablation of the Retrograde Fast Pathway as Treatment for AVNRT (Cryo-FP Trial)
Phase < 1
Waitlist Available
Research Sponsored by Lawson Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group
Summary
This trial will study a new, less risky ablation technique for a heart condition called atrioventricular nodal reentrant tachycardia.
Eligible Conditions
- Heart Block
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Termination of AVNRT
Secondary study objectives
Cardiac tamponade
Freedom from recurrence
Incidence of AV block
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: AblationExperimental Treatment1 Intervention
Mapping and ablation of the retrograde fast pathway with cryotherapy
Group II: MappingActive Control1 Intervention
Standard treatment involving ablation of the slow pathway with cryotherapy
Find a Location
Who is running the clinical trial?
Lawson Health Research InstituteLead Sponsor
681 Previous Clinical Trials
431,320 Total Patients Enrolled
1 Trials studying Heart Block
160 Patients Enrolled for Heart Block
University of Western Ontario, CanadaOTHER
166 Previous Clinical Trials
319,338 Total Patients Enrolled